WikiMD is world's largest health encyclopedia with
28,594 pages, 4,000,824 edits & 34,551,964 views.
111In-ibritumomab tiuxetan
(... ih-brih-TOO-moh-mab ty-UK-seh-tan) A radiolabeled monoclonal antibody used to find certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the diagnosis of other types of B-cell tumors. 111In-ibritumomab tiuxetan is made up of the monoclonal antibody ibritumomab plus the radioisotope indium In 111. It binds to a protein called CD20, which is found on B cells. A machine is used to find which cells in the body have taken up 111In-ibritumomab tiuxetan. 111In-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 111In-Zevalin and indium In 111-ibritumomab tiuxetan.
/
External links
WikiMD needs you!
This WikiMD article 111In-ibritumomab tiuxetan is a stub.
If you are a healthcare professional familiar with the topic 111In-ibritumomab tiuxetan, or
A subject matter expert or authority on 111In-ibritumomab tiuxetan, you can help us.
About | Mission | Paid editors welcome!
| 111In-ibritumomab tiuxetan is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
|---|
| Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
